coumarin has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
2H-chromen-2-one: coumarin derivative
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mbaba, M | 1 |
| Dingle, LMK | 1 |
| Zulu, AI | 1 |
| Laming, D | 1 |
| Swart, T | 1 |
| de la Mare, JA | 1 |
| Hoppe, HC | 1 |
| Edkins, AL | 1 |
| Khanye, SD | 1 |
1 other study available for coumarin and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Coumarin-Annulated Ferrocenyl 1,3-Oxazine Derivatives Possessing In Vitro Antimalarial and Antitrypanosomal Potency.
Topics: Antimalarials; Antiprotozoal Agents; Cell Proliferation; Cell Survival; Coumarins; Female; Ferrous C | 2021 |